標(biāo)題: Titlebook: Cost Versus Benefit in Cancer Care; Basil A. Stoll (Honorary Consulting Physician) Textbook 1988Latest edition The Editor and the Contribu [打印本頁] 作者: Prehypertension 時(shí)間: 2025-3-21 16:32
書目名稱Cost Versus Benefit in Cancer Care影響因子(影響力)
書目名稱Cost Versus Benefit in Cancer Care影響因子(影響力)學(xué)科排名
書目名稱Cost Versus Benefit in Cancer Care網(wǎng)絡(luò)公開度
書目名稱Cost Versus Benefit in Cancer Care網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cost Versus Benefit in Cancer Care被引頻次
書目名稱Cost Versus Benefit in Cancer Care被引頻次學(xué)科排名
書目名稱Cost Versus Benefit in Cancer Care年度引用
書目名稱Cost Versus Benefit in Cancer Care年度引用學(xué)科排名
書目名稱Cost Versus Benefit in Cancer Care讀者反饋
書目名稱Cost Versus Benefit in Cancer Care讀者反饋學(xué)科排名
作者: oncologist 時(shí)間: 2025-3-21 21:52
Hans-Dieter Klingemann,Max Kaasential variation in clinical management within national boundaries, probably more so than in the USA where a more informed, voluble and demanding society tends to reduce the scope for variation in clinical practice. Certainly, the medical profession in the United Kingdom enjoys greater autonomy than do USA clinicians [9].作者: 一個(gè)姐姐 時(shí)間: 2025-3-22 02:05
Wilhelm Bürklin,Russell J. Daltonuent in medical journals and in the lay press. Most hospitals have medical staff policies about ‘do not resuscitate’ orders, and many hospitals have established ethics committees to facilitate discussions and decision making.作者: 危險(xiǎn) 時(shí)間: 2025-3-22 07:47
ch as in the USA [1], and such a finding makes one ask whether it results from different resource availability or from different treatment objectives in the two countries. In this respect the report quotes a British oncologist as saying that US doctors ‘confuse activity with progress’.作者: 取回 時(shí)間: 2025-3-22 11:13
What is Overtreatment in Cancer?n little can be achieved, and from the scientific need to develop new diagnostic or treatment methods. Yet, many physicians believe that treatment should be guided solely by clearly defined need in the patient and a high likelihood of benefit.作者: Engulf 時(shí)間: 2025-3-22 15:39 作者: Engulf 時(shí)間: 2025-3-22 18:41
Dying with Dignity: A United States Viewuent in medical journals and in the lay press. Most hospitals have medical staff policies about ‘do not resuscitate’ orders, and many hospitals have established ethics committees to facilitate discussions and decision making.作者: Nmda-Receptor 時(shí)間: 2025-3-22 21:32
Rationing Cancer Care: A European Viewch as in the USA [1], and such a finding makes one ask whether it results from different resource availability or from different treatment objectives in the two countries. In this respect the report quotes a British oncologist as saying that US doctors ‘confuse activity with progress’.作者: characteristic 時(shí)間: 2025-3-23 03:52 作者: 加劇 時(shí)間: 2025-3-23 08:56
ed branches of medicine, tempered with humanism. This necessarily implies a multidisciplinary approach. This chapter aims to survey the ways in which the differing contributions have been brought together in the UK and Europe, and to draw some conclusions about future trends in the care of dying cancer patients.作者: pellagra 時(shí)間: 2025-3-23 11:25
because of the prevailing social ethic that holds that all individuals, irrespective of their ability to pay, must have access to essential care. Therefore, approximately 70 percent of all health care expenditure in the USA is provided by government and insurance, which contribute roughly 40 percent and 30 percent respectively.作者: 壕溝 時(shí)間: 2025-3-23 15:04
anagement in the advanced cancer patient. These differences reflect marked contrasts in the . of treatment and they obviously affect the cost of treatment, whether it is borne by the patient or the state.作者: Foregery 時(shí)間: 2025-3-23 20:54 作者: verdict 時(shí)間: 2025-3-24 00:02
Dying with Dignity: A British Viewed branches of medicine, tempered with humanism. This necessarily implies a multidisciplinary approach. This chapter aims to survey the ways in which the differing contributions have been brought together in the UK and Europe, and to draw some conclusions about future trends in the care of dying cancer patients.作者: 呼吸 時(shí)間: 2025-3-24 04:05 作者: HUMP 時(shí)間: 2025-3-24 07:21
Saying No is Difficult in Canceranagement in the advanced cancer patient. These differences reflect marked contrasts in the . of treatment and they obviously affect the cost of treatment, whether it is borne by the patient or the state.作者: restrain 時(shí)間: 2025-3-24 14:12
Gabriele Eckstein,Franz Urban Pappiprevention (i.e. reducing tobacco use and changing dietary habits), achieving recommended cancer screening measures, and wider application of the gains that have been made from new cancer treatment methods [6,7].作者: 意外 時(shí)間: 2025-3-24 16:52 作者: 折磨 時(shí)間: 2025-3-24 20:14
Max Kaase,Hans-Dieter Klingemanne and what societies can afford. Yet another gap exists between the realities of health policy and the medical profession’s expectations, particularly in respect of attaining the technological frontier. Health care, not surprisingly, is under siege.作者: Extricate 時(shí)間: 2025-3-25 01:18
https://doi.org/10.1007/978-3-322-86406-2elatives, professional colleagues and not least, from desperate patients themselves. They also come from the professional need to appear busy even when little can be achieved, and from the scientific need to develop new diagnostic or treatment methods. Yet, many physicians believe that treatment sho作者: duplicate 時(shí)間: 2025-3-25 06:23 作者: 執(zhí) 時(shí)間: 2025-3-25 11:03 作者: pus840 時(shí)間: 2025-3-25 11:56
Gebhard Kirchg?ssner,Bruno S. Freyrom the society at large that are utterly unrealistic on a day-to-day basis. They are asked to be Renaissance men and women in an age when that is no longer possible; they are expected to be ultimate healers, technological wizards, total authorities. (When a physician refuses to accept those expecta作者: MAL 時(shí)間: 2025-3-25 18:03
Jürgen W. Falter,Siegfried Schumannncer. Most practitioners in the UK feel that their prime duty is to the individual patient, and only secondarily to the economic consequences of their actions. The British primary care physician is thus free to refer the patient with cancer to any of the local hospital consultants who in turn, have 作者: 小平面 時(shí)間: 2025-3-25 23:17
Wilhelm Bürklin,Russell J. Daltonresearch now proceeds through various ‘phases’ and this process is regarded as critical to the development of new forms of treatment. To measure the costs and benefits of clinical cancer research is complex, and must be tackled from the perspective of society as well as from that of the individual p作者: 拘留 時(shí)間: 2025-3-26 03:41
Wilhelm Bürklin,Russell J. Daltonlness are much more open than they were 10 years ago. Discussions of ethical dilemmas about life-sustaining treatment and about terminal care are frequent in medical journals and in the lay press. Most hospitals have medical staff policies about ‘do not resuscitate’ orders, and many hospitals have e作者: 憎惡 時(shí)間: 2025-3-26 06:04 作者: ARY 時(shí)間: 2025-3-26 11:47 作者: SPECT 時(shí)間: 2025-3-26 16:19 作者: adroit 時(shí)間: 2025-3-26 18:07
vestigation, and among professionals about indefinite struggles to maintain life in moribund patients. Because of its emotional overtones, public discussion tends to be muted in the case of cancer, but physicians are well aware of gross contrasts between Europe and the USA in the aggressiveness of m作者: 箴言 時(shí)間: 2025-3-26 23:47 作者: 有害 時(shí)間: 2025-3-27 04:45 作者: 啞巴 時(shí)間: 2025-3-27 09:20 作者: micronized 時(shí)間: 2025-3-27 12:51
Wilhelm Bürklin,Russell J. Daltonresearch now proceeds through various ‘phases’ and this process is regarded as critical to the development of new forms of treatment. To measure the costs and benefits of clinical cancer research is complex, and must be tackled from the perspective of society as well as from that of the individual patient.作者: artless 時(shí)間: 2025-3-27 16:39 作者: 單調(diào)性 時(shí)間: 2025-3-27 18:17
Focus on Clinical Trialsresearch now proceeds through various ‘phases’ and this process is regarded as critical to the development of new forms of treatment. To measure the costs and benefits of clinical cancer research is complex, and must be tackled from the perspective of society as well as from that of the individual patient.作者: achlorhydria 時(shí)間: 2025-3-28 01:53
Textbook 1988Latest editionAn attempt to expose the dilemma between cost and benefit in the treatment of advanced cancer. It is written primarily for those physicians who ultimately have to make the choices in allocating resources, and discusses the reasons for differences in treatment between Europe and the USA.作者: 使苦惱 時(shí)間: 2025-3-28 03:40
https://doi.org/10.1007/978-1-349-09296-3amyotrophic lateral sclerosis (ALS); cancer; care; clinical trial; treatment作者: gout109 時(shí)間: 2025-3-28 06:17
The Editor and the Contributors 1988作者: Common-Migraine 時(shí)間: 2025-3-28 14:23 作者: oncologist 時(shí)間: 2025-3-28 14:43
What is Overtreatment in Cancer?elatives, professional colleagues and not least, from desperate patients themselves. They also come from the professional need to appear busy even when little can be achieved, and from the scientific need to develop new diagnostic or treatment methods. Yet, many physicians believe that treatment sho作者: 小臼 時(shí)間: 2025-3-28 22:05
What is Best for the Patient? A United States View1981 survived for at least five years, compared with an estimated 38% in 1960–1963 [5]. However, the number of patients that have state-of-the-art therapy available to them is still relatively small because of the great variability in the expertise and resources within our health care system. The Na作者: fluffy 時(shí)間: 2025-3-29 00:50
What is Best for the Patient? A European Viewical care, in the extent to which health services are privatised or nationalised, and in the approach to management by doctors. There is also a substantial variation in clinical management within national boundaries, probably more so than in the USA where a more informed, voluble and demanding socie作者: radiograph 時(shí)間: 2025-3-29 05:24
The Patient’s Expectations in the United Statesrom the society at large that are utterly unrealistic on a day-to-day basis. They are asked to be Renaissance men and women in an age when that is no longer possible; they are expected to be ultimate healers, technological wizards, total authorities. (When a physician refuses to accept those expecta作者: 憤慨一下 時(shí)間: 2025-3-29 10:18 作者: 法律的瑕疵 時(shí)間: 2025-3-29 15:06
Focus on Clinical Trialsresearch now proceeds through various ‘phases’ and this process is regarded as critical to the development of new forms of treatment. To measure the costs and benefits of clinical cancer research is complex, and must be tackled from the perspective of society as well as from that of the individual p作者: 陰險(xiǎn) 時(shí)間: 2025-3-29 19:01 作者: 逃避責(zé)任 時(shí)間: 2025-3-29 23:08 作者: CUB 時(shí)間: 2025-3-30 01:10
Rationing Cancer Care: A United States Viewn. They differ only in the instruments which they employ to accomplish their objective of allocating scarce resources among competing needs. A capitalist society such as the USA which relies heavily on ‘the market’ to perform the rationing, is restrained from doing so in the case of health services 作者: languid 時(shí)間: 2025-3-30 08:04
Rationing Cancer Care: A European Viewther than demand. As an example, the British expenditure on chemotherapy in cancer is on a per capita basis, reported to be only about one-fifth as much as in the USA [1], and such a finding makes one ask whether it results from different resource availability or from different treatment objectives 作者: brother 時(shí)間: 2025-3-30 11:38 作者: abduction 時(shí)間: 2025-3-30 13:12
